Molecular pharmacology of isoprostanes in vascular smooth muscle

被引:14
作者
Habib, A
Badr, KF
机构
[1] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon
[2] Amer Univ Beirut, Dept Biochem, Beirut, Lebanon
关键词
isoprostanes; platelet; vascular cells; constriction; signaling;
D O I
10.1016/j.chemphyslip.2003.10.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Isoprostanes are marker of lipid peroxidation and are produced after free-radical attack of membrane lipids. In addition, they are biologically active and are essentially vaso- and broncho-constrictor. Their smooth muscle constrictor actions are closely linked to the activation of the thromboxane A(2) receptor, but also involve a distinct receptor not yet identified. The response of vascular smooth muscle to isoprostanes is subclass-specific (F-series versus E-series isoprostanes) and cell- and species-related. In this review. we will address the vascular actions of isoprostanes and their possible role in vascular physiology and pathophysiology. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 40 条
[21]   Intracellular signaling by 8-epi-prostaglandin F-2 alpha is mediated by thromboxane A(2)/prostaglandin endoperoxide receptors in porcine carotid arteries [J].
Mohler, ER ;
Franklin, MT ;
Adam, LP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) :915-923
[22]   F2-isoprostanes mediate high glucose-induced TGF-β synthesis and glomerular proteinuria in experimental type I diabetes [J].
Montero, A ;
Munger, KA ;
Khan, RZ ;
Valdivielso, JM ;
Morrow, JD ;
Guasch, A ;
Ziyadeh, FN ;
Badr, KF .
KIDNEY INTERNATIONAL, 2000, 58 (05) :1963-1972
[23]   Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers [J].
Montuschi, P ;
Collins, JV ;
Ciabattoni, G ;
Lazzeri, N ;
Corradi, M ;
Kharitonov, SA ;
Barnes, PJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) :1175-1177
[24]   INCREASE IN CIRCULATING PRODUCTS OF LIPID-PEROXIDATION (F-2-ISOPROSTANES) IN SMOKERS - SMOKING AS A CAUSE OF OXIDATIVE DAMAGE [J].
MORROW, JD ;
FREI, B ;
LONGMIRE, AW ;
GAZIANO, JM ;
LYNCH, SM ;
SHYR, Y ;
STRAUSS, WE ;
OATES, JA ;
ROBERTS, LJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (18) :1198-1203
[25]   The isoprostanes - Their role as an index of oxidant stress status in human pulmonary disease [J].
Morrow, JD ;
Roberts, LJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (12) :S25-S30
[26]   Localization of distinct F-2-isoprostanes in human atherosclerotic lesions [J].
Pratico, D ;
Iuliano, L ;
Mauriello, A ;
Spagnoli, L ;
Lawson, JA ;
Maclouf, J ;
Violi, F ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) :2028-2034
[27]  
Pratico D, 1998, J INVEST MED, V46, P51
[28]   The isoprostanes in biology and medicine [J].
Praticò, D ;
Lawson, JA ;
Rokach, J ;
FitzGerald, GA .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (06) :243-247
[29]   Generation of 8-epiprostaglandin F-2 alpha by human monocytes - Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2 [J].
Pratico, D ;
FitzGerald, GA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :8919-8924
[30]  
Praticò D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO